Company: ISRG
Filing Date: 2025-04-23
Form Type: 10-Q
Source: 0001035267-25-000109
Chunk: 22

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-04-23
Form: 10-Q
Item: Item 1
Chunk 22
---
 comprehensive income (loss)— — — — 3.5 3.5 (0.4)3.1 Cash dividends declared and payable by joint venture— — — — — — (8.0)(8.0)Net income attributable to noncontrolling interest in joint venture— — — — — — 2.5 2.5 Ending balance354.7 $0.4 $8,903.0 $5,067.9 $(8.7)$13,962.6 $83.8 $14,046.4 

Stock Repurchase ProgramThe Company’s Board of Directors (the “Board”) has authorized an aggregate of $10.0 billion of funding for the Company’s common stock repurchase program (the “Repurchase Program”) since its establishment in March 2009. The most recent authorization occurred in July 2022, when the Board increased the authorized amount available under the Repurchase Program to $3.5 billion, including amounts remaining under previous authorization. As of March 31, 2025, the remaining amount of share repurchases authorized by the Board under the Repurchase Program was approximately $1.1 billion.The Company did not make any stock repurchases during the three months ended March 31, 2025, and 2024.

17

Accumulated Other Comprehensive Loss, Net of Tax, Attributable to Intuitive Surgical, Inc.The components of accumulated other comprehensive loss, net of tax, attributable to Intuitive Surgical, Inc. are as follows (in millions):Three Months Ended March 31, 2025 Gains on Hedge InstrumentsUnrealized Gains (Losses) on Available-for-Sale SecuritiesForeign Currency Translation LossesEmployee Benefit PlansTotalBeginning balance$11.0 $(14.6)$(33.1)$(14.6)$(51.3)Other comprehensive income (loss) before reclassifications(16.0)29.1 5.4 — 18.5 Amounts reclassified from accumulated other comprehensive income5.6 — — 0.1 5.7 Net current-period other comprehensive income (loss)(10.4)29.1 5.4 0.1 24.2 Ending balance$0.6 $14.5 $(27.7)$(14